SCHEMBL20109138

SCHEMBL20109138

C/C=C(\CC)P1(=O)N(c2ccccc2)CCN1c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.36
CHRNA7 P36544 2/20 0.35
BLM P54132 1/20 0.34
HTT P42858 2/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
MAPK1 P28482 1/20 0.34
DRD2 P14416 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
ESR1 P03372 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
GAA P10253 1/20 0.31
GFER P55789 1/20 0.31
TSHR P16473 2/20 0.31
USP2 O75604 1/20 0.31
ALOX15 P16050 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109139 1.00 MAPT (0.36) MAPTCHRNA7BLMHTTALDH1A1
SCHEMBL20109137 0.88 CHRNA7 (0.33) MAPTCHRNA7BLMHTTALDH1A1
SCHEMBL20109141 0.88 CHRNA7 (0.33) MAPTCHRNA7BLMHTTALDH1A1
SCHEMBL20109133 0.86 TSHR (0.40) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL20109135 0.85 TRPA1 (0.32) MAPTCHRNA7BLMALDH1A1DRD2
SCHEMBL17595812 0.84 RBP4 (0.35) MAPTHTTALDH1A1POLBMAPK1
SCHEMBL17596496 0.84 RBP4 (0.35) MAPTHTTALDH1A1POLBMAPK1
SCHEMBL20109216 0.82 MAPT (0.37) MAPTCHRNA7BLMHTTALDH1A1
SCHEMBL20109213 0.82 MAPT (0.37) MAPTCHRNA7BLMHTTALDH1A1
SCHEMBL20109239 0.82 MAPT (0.37) MAPTCHRNA7BLMMAPK1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 MAPT 4371/4885CHRNA7 3780/4885BLM 3535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.